These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36545037)

  • 1. Moderators of ayahuasca's biological antidepressant action.
    de Sousa GM; de Oliveira Tavares VD; de Menezes Galvão AC; de Almeida RN; Palhano-Fontes F; Lobão-Soares B; de Morais Freire FA; Nunes EA; Maia-de-Oliveira JP; Perkins D; Sarris J; de Araujo DB; Galvão-Coelho NL
    Front Psychiatry; 2022; 13():1033816. PubMed ID: 36545037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls.
    Galvão ACM; de Almeida RN; Silva EADS; Freire FAM; Palhano-Fontes F; Onias H; Arcoverde E; Maia-de-Oliveira JP; de Araújo DB; Lobão-Soares B; Galvão-Coelho NL
    Front Psychiatry; 2018; 9():185. PubMed ID: 29867608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.
    de Almeida RN; Galvão ACM; da Silva FS; Silva EADS; Palhano-Fontes F; Maia-de-Oliveira JP; de Araújo LB; Lobão-Soares B; Galvão-Coelho NL
    Front Psychol; 2019; 10():1234. PubMed ID: 31231276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca.
    Galvão-Coelho NL; de Menezes Galvão AC; de Almeida RN; Palhano-Fontes F; Campos Braga I; Lobão Soares B; Maia-de-Oliveira JP; Perkins D; Sarris J; de Araujo DB
    J Psychopharmacol; 2020 Oct; 34(10):1125-1133. PubMed ID: 32648790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
    Palhano-Fontes F; Barreto D; Onias H; Andrade KC; Novaes MM; Pessoa JA; Mota-Rolim SA; Osório FL; Sanches R; Dos Santos RG; Tófoli LF; de Oliveira Silveira G; Yonamine M; Riba J; Santos FR; Silva-Junior AA; Alchieri JC; Galvão-Coelho NL; Lobão-Soares B; Hallak JEC; Arcoverde E; Maia-de-Oliveira JP; Araújo DB
    Psychol Med; 2019 Mar; 49(4):655-663. PubMed ID: 29903051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.
    Perkins D; Pagni BA; Sarris J; Barbosa PCR; Chenhall R
    Front Pharmacol; 2022; 13():884703. PubMed ID: 36386199
    [No Abstract]   [Full Text] [Related]  

  • 8. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers.
    Murphy-Beiner A; Soar K
    Psychopharmacology (Berl); 2020 Apr; 237(4):1161-1169. PubMed ID: 31927605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra-Virgin Olive Oil Improves Depression Symptoms Without Affecting Salivary Cortisol and Brain-Derived Neurotrophic Factor in Patients With Major Depression: A Double-Blind Randomized Controlled Trial.
    Foshati S; Ghanizadeh A; Akhlaghi M
    J Acad Nutr Diet; 2022 Feb; 122(2):284-297.e1. PubMed ID: 34358723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.
    de Meiroz Grilo MLP; de Sousa GM; de Mendonça LAC; Lobão-Soares B; de Sousa MBC; Palhano-Fontes F; de Araujo DB; Perkins D; Hallak JEC; Galvão-Coelho NL
    Front Behav Neurosci; 2022; 16():901425. PubMed ID: 36408451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
    Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.
    Pasquini L; Palhano-Fontes F; Araujo DB
    J Psychopharmacol; 2020 Jun; 34(6):623-635. PubMed ID: 32255395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical structural differences following repeated ayahuasca use hold molecular signatures.
    Mallaroni P; Mason NL; Kloft L; Reckweg JT; van Oorsouw K; Ramaekers JG
    Front Neurosci; 2023; 17():1217079. PubMed ID: 37869513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of ayahuasca in a juvenile non-human primate model of depression.
    da Silva FS; Silva EAS; Sousa GM; Maia-de-Oliveira JP; Soares-Rachetti VP; de Araujo DB; Sousa MBC; Lobão-Soares B; Hallak J; Galvão-Coelho NL
    Braz J Psychiatry; 2019; 41(4):280-288. PubMed ID: 30427388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ayahuasca's therapeutic potential: What we know - and what not.
    Maia LO; Daldegan-Bueno D; Wießner I; Araujo DB; Tófoli LF
    Eur Neuropsychopharmacol; 2023 Jan; 66():45-61. PubMed ID: 36368095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Major Depression by Clinical Stages.
    de Menezes Galvão AC; Almeida RN; de Sousa GM; Leocadio-Miguel MA; Palhano-Fontes F; de Araujo DB; Lobão-Soares B; Maia-de-Oliveira JP; Nunes EA; Hallak JEC; Schuch FB; Sarris J; Galvão-Coelho NL
    Front Psychol; 2021; 12():641779. PubMed ID: 34421705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction'.
    Talin P; Sanabria E
    Int J Drug Policy; 2017 Jun; 44():23-30. PubMed ID: 28432902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ayahuasca's Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness.
    Mian MN; Altman BR; Earleywine M
    J Psychoactive Drugs; 2020; 52(2):130-137. PubMed ID: 31570056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.
    Hsu TW; Tsai CK; Kao YC; Thompson T; Carvalho AF; Yang FC; Tseng PT; Hsu CW; Yu CL; Tu YK; Liang CS
    BMJ; 2024 Aug; 386():e078607. PubMed ID: 39168500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin-Induced Physiological and Psychological Sickness Responses in Healthy Humans: Insights into the Post-Acute Phase.
    Engler H; Brinkhoff A; Wilde B; Kribben A; Rohn H; Witzke O; Schedlowski M; Benson S
    Neuroimmunomodulation; 2023; 30(1):268-276. PubMed ID: 37797587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.